SCHEMBL6692393

SCHEMBL6692393

COc1ccc(Oc2c(Cl)c(F)nc(F)c2Cl)cc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.39
▸ RORC P51449 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.37
▸ TUBB1 Q9H4B7 3/20 0.37
▸ KDR P35968 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ NPBWR1 P48145 2/20 0.36
▸ ENPP3 O14638 1/20 0.36
▸ ENPP1 P22413 1/20 0.36
▸ MCHR1 Q99705 1/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35
▸ TUBB4B P68371 1/20 0.35
▸ TUBB3 Q13509 1/20 0.35
▸ TUBB2A Q13885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6694189 0.84 TUBB1 (0.54) THRBRORCALDH1A1TUBB1TUBB4A
SCHEMBL6693009 0.82 KDM4E (0.49) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL6694690 0.82 RORC (0.56) THRBRORC
SCHEMBL6697148 0.82 MAPK1 (0.37) THRBRORCALDH1A1MAPTMEN1
SCHEMBL6692440 0.81 THRB (0.36) THRBRORCALDH1A1MAPTPOLB
SCHEMBL6693303 0.81 TUBB1 (0.46) ALDH1A1TUBB1MAPTPOLBNPBWR1
SCHEMBL6694977 0.81 L3MBTL1 (0.42) ALDH1A1NPBWR1MCHR1MEN1KMT2A
SCHEMBL6691486 0.79 ALDH1A1 (0.48) ALDH1A1MAPTNPBWR1MCHR1MEN1
SCHEMBL6692435 0.79 SMN1; SMN2 (0.39) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL22959367 0.73 THRB (0.49) THRBRORCALDH1A1TUBB1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6747048-B2 TREATING DISEASES OR DISORDERS ASSOCIATED WITH METABOLISM DYSFUNCTION OR WHICH ARE DEPENDENT UPON THE EXPRESSION OF A T3 REGULATED GENE, BRISTOL-MYERS SQUIBB COMPANY 2004-06-08 — — US disclosed
US-20040039028-A1 Pyridine-based thyroid receptor ligands BRISTOL-MYERS SQUIBB COMPANY 2004-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039028-A1 Pyridine-based thyroid receptor ligands TSHR, THRB, THRA THRB 2/4885RORC 173/4885ALDH1A1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback